MAPK3 and hepatocellular carcinoma: In our previous study, in which HCC cells were exposed to lenvatinib and cultured long-term to establish resistant HCC cells, the activation of ERK1 signaling was observed in all three lenvatinib-resistant HCC cell lines, including Huh-7, Hep3B, and Li-7, and was associated with resistance mechanisms [220].